Temporal changes in survival among adult patients with acute myeloid leukaemia in the period 2000-2016: a Danish population-based study

Lasse Hjort Jakobsen, Anne Stidsholt Roug, Andreas Kiesbye Øvlisen, Claus Werenberg Marcher, Hans Beier Ommen, Kim Theilgaard-Mönch, Peter Møller, Claudia Schöllkopf, Daniel Kristensen, Therese Maria Henriette Naur, Martin Bøgsted, Tarec Christoffer El-Galaly, Marianne Tang Severinsen

Publikation: Bidrag til tidsskriftArtikelForskningpeer review

Abstract

In the present study, we quantify the progress in overall survival (OS) during the period 2000-2016 among Danish patients with acute myeloid leukaemia (AML). This population-based study, including 3820 adult patients with AML, demonstrates a significantly improved OS over time with the 2-year age-standardised OS increasing from 22% in 2002 to 31% in 2016. The improvement in OS was exclusively seen in patients with AML aged ≥50 years, with absolute improvements in 2-year OS from 2002 to 2016 of ≥10% among patients aged 50-75 years and a small absolute increase in those aged >75 years.

OriginalsprogEngelsk
Sider (fra-til)482-487
Antal sider6
TidsskriftBritish Journal of Haematology
Vol/bind193
Udgave nummer3
DOI
StatusUdgivet - maj 2021

Bibliografisk note

© 2020 British Society for Haematology and John Wiley & Sons Ltd.

Fingeraftryk

Udforsk hvilke forskningsemner 'Temporal changes in survival among adult patients with acute myeloid leukaemia in the period 2000-2016: a Danish population-based study' indeholder.

Citationsformater